On March 14, 2019, Acacia Research Corporation ("Acacia") announced that it has appointed two independent directors to its board of directors.  According to the SEC's complaint filed in the U.S. District Court for the Southern District of New York, the company's licensing and intellectual property business has suffered significant losses in the last six months.  The SEC's complaint alleges that Acacia violated the antifraud provisions of Section 17(a) of the Securities Act of 1933 ("Securities Act") and Section 10(b) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 thereunder, and that Acacia violated the antifraud provisions.  The complaint further alleges that Acacia violated the antifraud provision of Section 10(b) of the Exchange Act and Rule 10b-5 thereunder.  Without admitting or denying the allegations in the complaint, Acacia has agreed to the entry of a final judgment that permanently enjoins it from violating the antifraud provisions of Section 10(b) and Rule 10b-5 of the Exchange Act and Rules 10b-5 and 10b-5 thereunder.  The settlement is subject to approval by the court.  The SEC's complaint charges Acacia with violating the antifraud provisions of Section 17(b)(5) of the Securities Act and Section 10(b) of the Exchange Act.  The complaint seeks permanent injunctions, disgorgement of ill-gotten gains with prejudgment interest, and civil penalties.  The SEC's investigation, which is continuing, has been conducted by Janney Montgomery and Ann Patricia Adler of the SEC's Boston Regional Office.  The litigation will be led by Brett Reiss and Ann Patricia Adler.  The SEC appreciates the assistance of the U.S. Attorney's Office for the Southern District of New York and the Federal Bureau of Investigation.  The SEC's Office of Investor Education and Advocacy has issued anÂ Investor AlertÂ to encourage investors to check the background of anyone selling or offering them an investment using the free and simple search tool onÂ Investor.gov.